72 related articles for article (PubMed ID: 6566965)
1. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.
Datta NS; Wilson GN; Hajra AK
N Engl J Med; 1984 Oct; 311(17):1080-3. PubMed ID: 6566965
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome: the new player in ferroptosis.
Tang D; Kroemer G
Signal Transduct Target Ther; 2020 Nov; 5(1):273. PubMed ID: 33235217
[No Abstract] [Full Text] [Related]
3. Mixed coagulopathy in patient with peroxisomal disorder, Zellweger syndrome.
Farris N; Sandell A
Pediatr Blood Cancer; 2024 May; ():e31094. PubMed ID: 38773729
[No Abstract] [Full Text] [Related]
4. 1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.
S'aulis D; Khoury EA; Zabel M; Rizzo WB
Mol Genet Metab; 2020; 131(1-2):253-258. PubMed ID: 32800643
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Diseases: A Clinical and Molecular History.
Pavlakis SG; Hirano M
Pediatr Neurol; 2016 Oct; 63():3-5. PubMed ID: 27460527
[No Abstract] [Full Text] [Related]
6. Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues.
Janssen A; Gressens P; Grabenbauer M; Baumgart E; Schad A; Vanhorebeek I; Brouwers A; Declercq PE; Fahimi D; Evrard P; Schoonjans L; Collen D; Carmeliet P; Mannaerts G; Van Veldhoven P; Baes M
J Neurosci; 2003 Oct; 23(30):9732-41. PubMed ID: 14586000
[TBL] [Abstract][Full Text] [Related]
7. Glucose is toxic to glycosome-deficient trypanosomes.
Furuya T; Kessler P; Jardim A; Schnaufer A; Crudder C; Parsons M
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14177-82. PubMed ID: 12386344
[TBL] [Abstract][Full Text] [Related]
8. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.
Farooqui AA; Horrocks LA
J Mol Neurosci; 2001; 16(2-3):263-72; discussion 279-84. PubMed ID: 11478381
[TBL] [Abstract][Full Text] [Related]
9. Biochemistry of peroxisomes in health and disease.
Singh I
Mol Cell Biochem; 1997 Feb; 167(1-2):1-29. PubMed ID: 9059978
[TBL] [Abstract][Full Text] [Related]
10. Blood polyunsaturated fatty acids in patients with peroxisomal disorders. A multicenter study.
Martinez M; Mougan I; Roig M; Ballabriga A
Lipids; 1994 Apr; 29(4):273-80. PubMed ID: 8177020
[TBL] [Abstract][Full Text] [Related]
11. Lactic acidosis and mitochondrial dysfunction in two children with peroxisomal disorders.
Holmes RD; Moore KH; Ofenstein JP; Tsatsos P; Kiechle FL
J Inherit Metab Dis; 1993; 16(2):368-80. PubMed ID: 8105143
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor: the biosynthetic and catabolic enzymes.
Snyder F
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):689-705. PubMed ID: 7848265
[No Abstract] [Full Text] [Related]
13. Pelizaeus-Merzbacher disease. The Löwenberg-Hill type.
Bruyn GW; Weenink HR; Bots GT; Teepen JL; van Wolferen WJ
Acta Neuropathol; 1985; 67(3-4):177-89. PubMed ID: 4050332
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders.
Arias JA; Moser AB; Goldfischer SL
J Cell Biol; 1985 May; 100(5):1789-92. PubMed ID: 3988808
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of Zellweger syndrome and related disorders: impaired degradation of phytanic acid.
Poulos A; van Crugten C; Sharp P; Carey WF; Robertson E; Becroft DM; Saudubray JM; Poll-The BT; Christensen E; Brandt N
Eur J Pediatr; 1986 Dec; 145(6):507-10. PubMed ID: 3816854
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
Sturk A; Schaap MC; ten Cate JW; Heymans HS; Schutgens RB; Przyrembel H; Borst P
J Clin Invest; 1987 Feb; 79(2):344-50. PubMed ID: 3805272
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
[TBL] [Abstract][Full Text] [Related]
18. Computerized tomography and ultrasound in the diagnosis of cerebro-hepato-renal syndrome of Zellweger.
Weese-Mayer DE; Smith KM; Reddy JK; Salafsky I; Poznanski AK
Pediatr Radiol; 1987; 17(2):170-2. PubMed ID: 3550671
[TBL] [Abstract][Full Text] [Related]
19. Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).
Lazarow PB; Fujiki Y; Small GM; Watkins P; Moser H
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9193-6. PubMed ID: 3538019
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal disorders: a newly recognised group of genetic diseases.
Schutgens RB; Heymans HS; Wanders RJ; van den Bosch H; Tager JM
Eur J Pediatr; 1986 Feb; 144(5):430-40. PubMed ID: 3514227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
